Abstract: During cryotherapy, using an endoscope that extends within a patient to a cold treatment site, the device of the invention vacuums gas from the site through radial intake ports to a cylindrical space in an evacuation chamber held elastically circumferentially about the distal end of the endoscope tube that carries the cryoprobe to the site.

Abstract: During cryotherapy, using an endoscope that extends within a patient to a cold treatment site, the device of the invention vacuums gas from the site through radial intake ports to a cylindrical space in an evacuation chamber held elastically circumferentially about the distal end of the endoscope tube that carries the cryoprobe to the site.

Abstract: An endoscopic stain is provided that includes a carbon pigment and a suspending/viscosity-increasing agent in a pharmaceutically acceptable delivery vehicle, wherein the carbon pigment has a total level of polycyclic aromatic hydrocarbons (PAH) of not greater than 0.5 ppm. Methods of staining an internal site utilizing the stain of the invention and kits that include the stain of the invention are also provided.

Abstract: An endoscopic stain is provided that includes a carbon pigment and a suspending/viscosity-increasing agent in a pharmaceutically acceptable delivery vehicle, wherein the carbon pigment has a total level of polycyclic aromatic hydrocarbons (PAH) of not greater than 0.5 ppm. Methods of staining an internal site utilizing the stain of the invention and kits that include the stain of the invention are also provided.

Abstract: An endoscopic tissue staining composition comprises carbon and suspending/viscosity-increasing agent in a pharmaceutically acceptable delivery vehicle. In an embodiment, the composition includes carbon black, activated carbon or unactivated carbon, suspending/viscosity-increasing agent, anti-foaming agent and surfactant. In a particular embodiment, the composition includes 0.01% to 1.0% carbon, 5.0% to 25% suspending/viscosity-increasing agent such as glycerol, 0.005% to 0.05% anti-foaming agent such as simethicone, 0.5% to 1.5% surfactant such as polyoxyethylene sorbitan esterified with fatty acid, and water. A method for staining of internal sites, particularly in the mucosal layers of the gastrointestinal tract, urinary bladder or lungs, includes injecting the composition in staining amount in proximity to the internal site. A kit includes the composition packaged with a means for endoscopic injection, preferably a syringe and sclerotherapy needle.